Jeffrey Barrett
Chief Tech/Sci/R&D Officer bei NIGHTINGALE HEALTH OYJ
Vermögen: 9 394 $ am 31.03.2024
Profil
Jeffrey Barrett is currently the Chief Scientific Officer at Nightingale Health Oyj since 2021.
Prior to this, he worked as the Director and Chief Scientific Officer at Genomics Plc.
He obtained a doctorate degree from the University of Oxford.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2023 | 8 364 ( 0,02% ) | 9 394 $ | 31.03.2024 |
Aktive Positionen von Jeffrey Barrett
| Unternehmen | Position | Beginn |
|---|---|---|
| NIGHTINGALE HEALTH OYJ | Chief Tech/Sci/R&D Officer | 27.09.2021 |
Ehemalige bekannte Positionen von Jeffrey Barrett
| Unternehmen | Position | Ende |
|---|---|---|
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Jeffrey Barrett
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NIGHTINGALE HEALTH OYJ | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Health Technology |
